No Picture
News

Poseida Therapeutics Reports Operational Update and Financial Results for Second Quarter and First Half of 2020

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to create cell and gene therapeutics with the capacity to cur… […]

No Picture
News

Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market

– DelMar Pharmaceuticals, Inc. Name Change to Kintara Therapeutics, Inc.- Kintara Therapeutics to Trade on Nasdaq Capital Market under the Ticker Symbol “KTRA”

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (formerly DelMar Pharm… […]

No Picture
News

Qualigen Therapeutics Announces Issuance of STARS(TM) Technology Patent by the U.S. Patent and Trademark Office

CARLSBAD, Calif., Aug. 20, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued patent No. 10,744,257 entitled “Devices and Methods f… […]

No Picture
News

Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress(TM) 2020

Oral Presentation to Highlight New Efficacy Data Measured at Week 16 and Additional Week 12 Efficacy Data Stratified by Baseline Characteristics and Risk Factors

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKT… […]

No Picture
News

Low-Cost Nafamostat Blocks SARS-CoV-2 Infection in Human Lung Cells, Preclinical Study Finds

Covistat repurposing generic pancreatitis remedy for oral, inhaled COVID-19 treatments

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — A preclinical study testing the low-cost generic drug nafamostat in human cells shows it can help block SARS-CoV-2 infecti… […]

No Picture
News

Salk scientist Tony Hunter receives National Cancer Institute Outstanding Investigator Award

LA JOLLA, CA—Salk scientist Tony Hunter has received a National Cancer Institute (NCI) Outstanding Investigator Award (OIA), which supports accomplished leaders in cancer research. Hunter, who is an American Cancer Society Professor, will receive more … […]

No Picture
News

National Study Finds Lyme Disease 10 Times Greater Than Reported to CDC; Quidel-Sponsored Webinar Reveals Prevalence and Patterns of Lyme Disease

SAN DIEGO–(BUSINESS WIRE)– #Infectiousdisease–The number of Americans afflicted with Lyme disease was found to be 10 times greater than the 30,000 cases reported each year by the CDC. […]

No Picture
News

Looking to expand beyond diabetes, Novo Nordisk enlists Evotec in CKD pact worth up to $179M per program

Most of Novo Nordisk’s kidney work has come from diabetes, but eyeing an R&D expansion, the Danish giant is putting money down on a pact to target chronic kidney disease directly.
The new deal comes with an old partner: the German drug discovery co… […]

No Picture
News

Biocept Awarded US Patent for proprietary Primer-Switch Mutation Detection and Amplification Improvement Platform Used to Detect Rare Cell Mutations, Including Cancer Biomarkers

Expands Company’s patent portfolio and marks another step in pursuit of worldwide intellectual property protection for proprietary Primer-Switch technology used to detect rare events such as cancer biomarkers found in tissue and liquid biopsies

SAN … […]

No Picture
News

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.

Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib

CARLSBAD, Calif., Aug. 17, 2020 /PRNewswire/ — Thermo Fisher Scientific has signed a companion diagnostic … […]

No Picture
News

Qualigen Therapeutics Announces Business Highlights and First Quarter Fiscal Year 2021 Financial Results; Has $16 Million in Cash on Hand as of Today

CARLSBAD, Calif., Aug. 14, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) today announced business highlights and financial results for the fiscal year 2021 first quarter, ended June 30, 2020.
Business hig… […]